BioCardia, Inc. - Product Pipeline Analysis, 2015 Update

Date: April 8, 2015
Pages: 22
Price:
US$ 750.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: BEFE20899DEEN
Leaflet:

Download PDF Leaflet

BioCardia, Inc. - Product Pipeline Analysis, 2015 Update
SUMMARY

BioCardia, Inc. (BioCardia) is a medical device company that develops various biointerventional solutions. The company offers catheters for delivery of therapeutic agents directly to the heart, and of guiding catheters for peripheral and coronary vasculature and chambers of the heart. Its helix biotherapeutic delivery catheter system is used for cardiovascular regenerative medicine. The company develops solutions for heart failure, chronic myocardial ischemia and acute myocardial infarction. It works with physician investigators and strategic partners to advance biotherapeutics and devices used in the treatment of cardiovascular diseases. BioCardia is headquartered in San Carlos, California, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

SCOPE:
  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company BioCardia, Inc.
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design, trial status and phase, estimated start and end date.
REASONS TO BUY:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
BioCardia, Inc. Company Snapshot
BioCardia, Inc. Company Overview
Key Information
BioCardia, Inc. Pipeline Products and Clinical Trials Overview
BioCardia, Inc. – Pipeline Analysis Overview
Key Facts
BioCardia, Inc. - Major Products and Services
BioCardia, Inc. Pipeline Products by Development Stage
BioCardia, Inc. Pipeline Products Overview
CardiAMP - Heart Failure
CardiAMP - Heart Failure Product Overview
Helical Infusion System
Helical Infusion System Product Overview
Helix Transendocardial Delivery System
Helix Transendocardial Delivery System Product Overview
BioCardia, Inc. - Key Competitors
BioCardia, Inc. - Key Employees
BioCardia, Inc. - Locations And Subsidiaries
Head Office
Recent Developments
BioCardia, Inc., Recent Developments
Nov 11, 2014: BioCardia Announces FDA Acceptance of Phase III Clinical Trial Protocol Studying Bone Marrow-Derived Cell Therapy for Heart Failure Patients
May 19, 2014: Phase II STOP-HF Trial Shows Excellent Safety Profile, Supports Efficacy for Juventas JVS-100 as Delivered by BioCardia Helix Transendocardial Delivery System
May 07, 2014: RECARDIO Clinical Trial Doses First Patient
Mar 17, 2014: BioCardia’s Morph AccessPro Steerable Introducer Receives CE Mark Approval
Jan 10, 2014: BioCardia Receives CE Mark for New Helix Transendocardial Delivery Catheter
Nov 18, 2013: Phase II TAC-HFT Trial Shows Excellent Safety Profile, Suggests Efficacy, for Transendocardial Delivery of Two Types of Autologous Cells for Ischemic Heart Failure
Nov 06, 2012: BioCardia Announces Positive Results From Phase I/II POSEIDON Trial Using Helical Infusion System
May 04, 2009: BioCardia's Morph AccessPro Steerable Introducer System Gains 510(k) Clearance
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

BioCardia, Inc., Key Facts
BioCardia, Inc. Pipeline Products and Clinical Trials Overview
BioCardia, Inc. Pipeline Products by Equipment Type
BioCardia, Inc. Pipeline Products by Indication
BioCardia, Inc., Key Facts
BioCardia, Inc., Major Products and Services
BioCardia, Inc. Number of Pipeline Products by Development Stage
BioCardia, Inc. Pipeline Products Summary by Development Stage
CardiAMP - Heart Failure - Product Status
CardiAMP - Heart Failure - Product Description
Helical Infusion System - Product Status
Helical Infusion System - Product Description
Helix Transendocardial Delivery System - Product Status
Helix Transendocardial Delivery System - Product Description
BioCardia, Inc., Key Employees

LIST OF FIGURES

BioCardia, Inc. Pipeline Products by Equipment Type
BioCardia, Inc. Pipeline Products by Development Stage
Skip to top


Ask Your Question

BioCardia, Inc. - Product Pipeline Analysis, 2015 Update
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: